Marlene Debel - Aug 9, 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP & Chief Risk Officer
Signature
/s/ Anna Nazarenko, Authorized Signer
Stock symbol
MET
Transactions as of
Aug 9, 2023
Transactions value $
-$100,692
Form type
4
Date filed
8/11/2023, 04:16 PM
Previous filing
Mar 2, 2023
Next filing
Sep 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Options Exercise $493K +10.9K +14.33% $45.15 87K Aug 9, 2023 Direct
transaction MET Common Stock Sale -$593K -9.39K -10.79% $63.18 77.6K Aug 9, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Options Exercise $0 -10.9K -100% $0.00* 0 Aug 9, 2023 Common Stock 10.9K $45.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on August 9, 2023 and related tax obligations and fees.
F2 The options became exercisable in three substantially equal installments on February 25, 2015, 2016 and 2017.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney